{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Health Affairs This Week","title":"PhRMA vs. CMS' GLOBE: The New Medicare Part B Drug Pricing Fight","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/6d4eb37d\"></iframe>","width":"100%","height":180,"duration":815,"description":"How far can international reference pricing go in lowering prescription drug costs?\nHealth Affairs Publishing's Jeff Byers welcomes Senior Editor Michael Gerber back to the pod to discuss the finalized GLOBE model for Medicare Part B drugs, the administration’s broader \"most favored nation\" strategy, the PhRMA lawsuit against CMS over the model, and what policy watchers should monitor in the months ahead.\nJoin Health Affairs Publishing on November 17 for an exclusive event with Jetson Leder-Luis, PhD of Boston University getting Insiders up to speed on fraud policies and what to watch in the health care industry moving forward.\nRelated Links:\nHealth Affairs Moves Exclusively Online (Health Affairs Forefront)\nCMS Finalizes New Mandatory Drug Payment Model to Deliver Lower Drug Prices for Beneficiaries in Original Medicare Part B\nAdministration Finalizes Medicare Part B International Reference Pricing Model (Health Affairs Forefront)\nPhRMA Challenges CMS’ MFN Policy as Unlawful Overreach (PhRMA)\nSign up for Health Affairs' free newsletter to catch up on our new articles, podcasts, and events.","thumbnail_url":"https://img.transistorcdn.com/1yTEmrg3NcfwPvygDcOosqdCKJnotdzHk5P0Oq8y-us/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzE2NjA3LzE2MDY4/MzkyNjUtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}